Keywords: Lupin, Lunesta, Dainippon Sumitomo, Par Pharma, Rythmol, Lotrel, Sedative, Antiarrhythmic, Antihypertensive

Lupin settles Lunesta patent litigation with Dainippon Sumitomo; Par Pharma starts shipping generic Rythmol and Lotrel

Article | 05 January 2011

Print This

Indian drugmaker Lupin, together with its US subsidiary, Lupin Pharmaceuticals, says it has settled all ongoing litigation over the sedative ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in